Dublin, Dec. 17, 2020 (GLOBE NEWSWIRE) -- The "Global Dermatology Partnering 2014-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.
The Global Dermatology Partnering 2014-2020: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.
The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.
Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
Global Dermatology Partnering 2014-2020 includes:
Trends in dermatology dealmaking in the biopharma industry since 2014
Analysis of dermatology deal structure
Access to headline, upfront, milestone and royalty data
Access to over 600 dermatology deal records
The leading dermatology deals by value since 2014
The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.
Available deals are listed by:
Stage of development at signing
Deal component type
Specific therapy target
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Dermatology dealmaking
2.2. Dermatology partnering over the years
2.3. Dermatology partnering by deal type
2.4. Dermatology partnering by industry sector
2.5. Dermatology partnering by stage of development
2.6. Dermatology partnering by technology type
2.7. Dermatology partnering by therapeutic indication
Chapter 3 -Financial deal terms for Dermatology partnering
3.2. Disclosed financials terms for Dermatology partnering
3.3. Dermatology partnering headline values
3.4. Dermatology deal upfront payments
3.5. Dermatology deal milestone payments
3.6. Dermatology royalty rates
Chapter 4 - Leading Dermatology deals and dealmakers
4.2. Most active in Dermatology partnering
4.3. List of most active dealmakers in Dermatology
4.4. Top Dermatology deals by value
Chapter 5 - Dermatology contract document directory
5.2. Dermatology partnering deals where contract document available
Chapter 6 - Dermatology dealmaking by therapeutic target
6.2. Deals by Dermatology therapeutic target
Appendix 1 - Directory of Dermatology deals by company A-Z 2014 to 2020
Appendix 2 - Directory of Dermatology deals by deal type 2014 to 2020
Appendix 3 - Directory of Dermatology deals by stage of development 2014 to 2020
Appendix 4 - Directory of Dermatology deals by technology type 2014 to 2020
For more information about this report visit https://www.researchandmarkets.com/r/d5vyj0
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900